Pentwater Capital Management LP Pure Tech Health PLC Transaction History

Pentwater Capital Management LP

  • $9.58 Billion
  • Q1 2024

A detailed history of Pentwater Capital Management LP transactions in Pure Tech Health PLC stock. As of the latest transaction made, Pentwater Capital Management LP holds 17,000 shares of PRTC stock, worth $382,500. This represents 0.01% of its overall portfolio holdings.

Number of Shares
17,000
Previous 10,244 65.95%
Holding current value
$382,500
Previous $288,000 68.06%
% of portfolio
0.01%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$22.05 - $29.4 $148,969 - $198,626
6,756 Added 65.95%
17,000 $484,000
Q4 2023

Feb 14, 2024
BUY
$17.08 - $28.18 $174,967 - $288,675
10,244 New
10,244 $288,000

Others Institutions Holding PRTC

# of Institutions
5
Shares Held
24.1K
Call Options Held
0
Put Options Held
0
View Full List

About PureTech Health plc

PRTC Quotes by TradingView
  • Ticker PRTC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 27,888,500
  • Market Cap $627M
  • Description
  • PureTech Health plc, a clinical-stage biotherapeutics company, discovers, develops, and commercializes medicines for inflammatory, fibrotic and immunological, intractable cancers, lymphatic and gastrointestinal, neurological and neuropsychological, and other diseases in the United States. The company offers KarXT targeting muscarinic acetylcholi...
More about PRTC
Track This Portfolio

Track Pentwater Capital Management LP Portfolio

Follow Pentwater Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pentwater Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Pentwater Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email